DISQUS

DISQUS Hello! Pharmababble is using DISQUS, a powerful comment system, to manage its comments. Learn more.

Community Page

Pharmababble

Stream of consciousness pharmaceuticals business development
Jump to original thread »
Author

Wanna Know Why Drug Discovery/Development Is Hard?

Started by TheEben · 6 months ago

FTY270 (fingolimod), an S1P1 modulator, is a T-cell specific immunosuppressant and is a hot, emerging phase III therapy for MS from Novartis (NVS). So where is the difficulty?
In the Aug. 14, 2008, issue of Nature, scientists from Emory University and the Yerkes Primate Rese ... Continue reading »

0 comments

This thread has no comments yet.

Add New Comment

Returning? Login